ClinConnect ClinConnect Logo
Search / Trial NCT02807948

SJM MRI Diagnostic Imaging Registry (IDE)

Launched by ABBOTT MEDICAL DEVICES · Jun 17, 2016

Trial Information

Current as of May 27, 2025

Completed

Keywords

Mri Scan, Pacemakers, Icd, Crt

ClinConnect Summary

This study will be performed as part of a regulated, prospective, non-randomized, multi-center clinical study.

Subjects will be enrolled, undergo a clinically-indicated MRI scan, and have an assessment of adverse events, device measurements, and clinical utility of the MRI scan images.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patient is implanted with a market-released St. Jude Medical pacemaker, ICD, or CRT current generation device listed in the study protocol and any market-released pacing or defibrillation lead.
  • 2. Patient's device and all leads must be implanted for at least 6 weeks prior to the scheduled date of the MRI.
  • 3. Patient has a clinical indication for a non-thoracic MRI scan, where MRI is the imaging modality of choice that will give adequate results to manage the patient.
  • 4. Patient is scheduled for a non-thoracic MRI scan up to 1.5T.
  • 5. Patient has a pacemaker, ICD, or CRT device implanted pectorally.
  • 6. Patient has the ability to provide informed consent for study participation and be willing and able to comply with the study procedures.
  • 7. Patient is 18 years or above, or of legal age to give informed consent specific to state and national law.
  • Exclusion Criteria:
  • 1. Patient has an ICD/CRT-D and is pacemaker dependent
  • 2. Capture threshold is greater than 2.5 volts at 0.5 ms for RA and RV leads
  • 3. Pacing lead impedance is NOT within range (i.e. ≥ 200 and ≤ 2000 ohms)
  • 4. High voltage lead impedance (HVLI) is NOT within range (i.e. ≥ 20 and ≤ 200 ohms)
  • 5. Patient has a device generator battery voltage at elective replacement interval (ERI)
  • 6. Patient has another existing active implanted medical device (e.g. neurostimulator, infusion pump, etc.) that has MR labeling that will not allow the MRI scans to be completed.
  • 7. Patient has other non-MRI compatible device or material implanted
  • NOTE:
  • MRI compatible knee replacements, hip replacements, stents, etc. may be included as long as the labeling of these devices allow MRI scans conducted per this protocol
  • MRI compatible mechanical, prosthetic, and bioprosthetic heart valves may be included as long as the labeling of these devices allow for MRI scans conducted per this protocol
  • Non-removable dental implants may be included
  • 8. Patient has a lead extender, adaptor, or capped/abandoned lead
  • 9. Patient is pregnant

About Abbott Medical Devices

Abbott Medical Devices is a leading global healthcare company dedicated to advancing medical technology through innovative research and development. With a robust portfolio of diagnostic, therapeutic, and monitoring solutions, Abbott is committed to improving patient outcomes and enhancing the quality of care across various medical fields. The company places a strong emphasis on clinical trials to validate the safety and efficacy of its products, ensuring compliance with regulatory standards and fostering collaboration with healthcare professionals. By leveraging cutting-edge science and technology, Abbott Medical Devices aims to address pressing health challenges and deliver transformative solutions that empower patients and healthcare providers alike.

Locations

Columbus, Ohio, United States

Bethesda, Maryland, United States

Rancho Mirage, California, United States

Portland, Oregon, United States

Norfolk, Virginia, United States

Pittsburgh, Pennsylvania, United States

Hartford, Connecticut, United States

Park Ridge, Illinois, United States

Kansas City, Kansas, United States

Shreveport, Louisiana, United States

Cleveland, Ohio, United States

Orlando, Florida, United States

Takoma Park, Maryland, United States

Lynchburg, Virginia, United States

Newark, Delaware, United States

Kansas City, Missouri, United States

Bellevue, Washington, United States

Jupiter, Florida, United States

Chattanooga, Tennessee, United States

Roslyn, New York, United States

Tyler, Texas, United States

Langhorne, Pennsylvania, United States

Littleton, Colorado, United States

Eugene, Oregon, United States

Loveland, Colorado, United States

San Francisco, California, United States

Scottsdale, Arizona, United States

Tucson, Arizona, United States

Fresno, California, United States

Concord, California, United States

Indianapolis, Indiana, United States

Fort Worth, Texas, United States

Springfield, Illinois, United States

Winston Salem, North Carolina, United States

Milwaukee, Wisconsin, United States

Newport Beach, California, United States

Sayre, Pennsylvania, United States

Saint Louis, Missouri, United States

Burbank, California, United States

Boca Raton, Florida, United States

Athens, Georgia, United States

Auburn Hills, Michigan, United States

Corvallis, Oregon, United States

Charleston, South Carolina, United States

Seattle, Washington, United States

Jonesboro, Arkansas, United States

Bakersfield, California, United States

Deer Park, California, United States

North Hollywood, California, United States

Santa Barbara, California, United States

Ashland, Kentucky, United States

Jackson, Mississippi, United States

Columbia, Missouri, United States

Kearney, Nebraska, United States

Denville, New Jersey, United States

Rochester, New York, United States

Allentown, Pennsylvania, United States

Danville, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Grant Kim

Study Director

Abbott Medical Devices

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials